Search

everythinglearnresearchcommunity

for

Search:↓

cGEL hydrogel improves melanin production in skin cells, making it a promising option for skin treatments.

NuMA-microtubule interactions are crucial for proper skin structure and hair growth.

Chemotherapy reduces splenic melanin in mice.

A sphingolipid from human placenta may help treat vitiligo by activating melanocyte stem cells.

Stem cell factor and certain proteins help melanocytes from hair follicles move and attach better, aiding vitiligo repigmentation.

Researchers successfully grew horse skin cells that produce pigment from hair follicle samples.

Hair follicle-derived melanocyte transplant could effectively treat vitiligo by restoring skin color.

Liposomes can safely and effectively deliver substances to mouse hair follicles, potentially useful for human hair treatments.

High S100B protein levels indicate poor survival in advanced melanoma.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

MOF controls skin development by regulating genes for mitochondria and cilia.

Different types of inactive melanocyte stem cells exist with unique characteristics and potential to develop into other cells.

RAGE is a potential target for melanoma treatment, but its effectiveness is uncertain due to variable expression levels.

Enhancing CD8+ T cell function to induce ferroptosis in tumor cells may help treat skin melanoma.

Hair follicle stem cells can become melanocytes to help treat skin depigmentation.

Nestin helps identify certain melanoma cells in nodular melanoma.

SLC45A2 and GPNMB genes help control chicken feather color by promoting melanin.

Mouse skin cancer progression involves a unique group of cells marked by ABCG2 and MTS24.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

Sox2 controls hair color by affecting pigment production in hair follicles.

CD34+ and CD34- melanocyte stem cells have different regenerative abilities.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Less differentiated melanoma cells are more vulnerable to a type of cell death, which could improve cancer treatments.

Unpigmented keratinocytes absorb substances faster, while melanocytes bind more strongly to melanin.

Keratinocytes can reverse the effects of the GNAQ oncogene, inhibiting melanoma cell growth.

Melatonin can affect skin color, treat skin conditions, and may help with skin cancer.

Tumor cell adhesion is linked to higher risk of SLN metastasis and melanoma recurrence, and a model including these factors predicts these outcomes better than one with just clinical data.